Both in Pharmaceuticals
Geron vs Wave Life Sciences
Over the past year GERN returned −23.2% and WVE returned −52.2%; their daily moves had a correlation of -0.00.
GERN −23.2% WVE −52.2%Growth of $1, one year, split-adjusted
| Metric | GERN | WVE |
|---|---|---|
| Price | $0.9830 | $3.64 |
| Market cap | $631.6M | $717.9M |
| Today | −14.52% | +5.51% |
| 1 month | −20.7% | 0.0% |
| 6 months | −34.9% | −48.4% |
| Year to date | −25.5% | −78.6% |
| 1 year | −23.2% | −52.2% |
| Revenue growth (YoY) | +17.2% | +72.9% |
| Gross margin | 83.9% | 100.0% |
| Net margin | −29.0% | −470.5% |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | 10.1× |
| Net cash | $51.1M | $430.7M |
| Dividend yield | — | — |
| Volatility (60d) | 71.2% | 63.0% |
| Short % of float | 11.9% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).